Lash, Timothy L., et al. “Breast Cancer Recurrence Risk Related to Concurrent Use of SSRI Antidepressants and Tamoxifen”. Acta Oncologica, vol. 49, no. 3, Jan. 2010, pp. 305-12, doi:10.3109/02841860903575273.